• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • Member Portal
  • Find a Nephrologist
IgA Nephropathy Foundation Logo
  • IgA Nephropathy Foundation Logo
  • About Us
        • MM About

          • About Us
          • Leadership Team
          • Board of Directors
          • Medical & Scientific Advisory Board
          • IgAN Go Global Network
        • MM About 2

          • Latest News, Media, and Tips
          • Our Partners
          • IgAN Ambassadors
          • Join The Newsletter
  • Events
        • Events

          • Calendar of Events
          • SPARK 2025
          • IgA Nephropathy Day
          • Rare Disease Day
  • Resources
        • MM – Resource 1

          • What is IgAN
          • Diagnosis
          • Understanding Your Lab Results
          • Understanding Your Biopsy
          • Understanding blood pressure and your kidneys
          • Treatment Options
        • MM – Resource 2

          • IgAN Info
          • Faces of IgAN
          • IgAN Risk Quiz
          • AAPI Higher Risk
          • IgAN Cookbook
          • IgAN FAQs
        • MM – Resource 3

          • Support Options
          • Patient Aid
          • IgANCare Program
          • Learn About Insurance
          • Patient + Care Partner Support
          • The IgA Nephropathy Foundation Ambassador Program
          • Caregiver Resources
          • Pregnancy and Family Planning
        • MM – Resource 4

          • Learning & Resources
          • IgAN+ App
          • Tools & Resources
          • Mental Health
          • Podcasts
          • IgAN Nutrition
          • IgAN Recipes
  • Research
        • MM Research

          • IgA Nephropathy Studies
          • IgA Nephropathy Research
          • Published Research Articles
        • MM Research 2

          • Clinical Trials
          • Considering a Clinical Trial?
          • View All Clinical Trials
  • Join
        • MM – Join 1

          • Become a Member
          • The IgA Nephropathy Foundation Ambassador Program
          • Ways to Give
          • Advocacy for IgAN
        • MM – Join 2

          • Join Our Newsletter
          • Patient Registry
  • Donate
  • IgANCare Program

Navigating IgA Nephropathy Treatment Decisions

Written by: The IgAN Team
  • 32Share on Facebook
  • 10Share on Twitter
  • 30Share on Pinterest
  • 20Share on Reddit
  • 12Share on LinkedIn
  • 25Share on Email

The good news is that you’re not alone and the future is bright when it comes to living with and managing IgA Nephropathy. There are more treatments being studied than ever before, including novel, targeted therapies designed to specifically treat IgA Nephropathy, one of which became the first to be approved by the U.S. Food and Drug Administration for use in certain adults. 

Finding out that you or a loved one has IgA Nephropathy can be scary and overwhelming, we know. You may feel flooded with emotions and perhaps a little uncertain about the road ahead and what it might mean for you and your family. 

Treatments can help

  • You feel better and more at ease
  • Control the symptoms of IgA Nephropathy
  • Prevent or delay end-stage kidney disease

Still, making decisions about your care isn’t always easy. Many people with IgA Nephropathy also have other health conditions to factor in too.

This section reviews factors that can shape treatment options, key considerations to keep in mind when gathering information and making decisions, as well as tips for playing an active role in your care so you fully understand your choices and can get the care you want.

To help, we’ve compiled useful information on Making Treatment Decisions.

Explore topic resources

Understanding Your Treatment Options

Thinking About What You Want from Treatment

Considering a Clinical Trial

6 Tips for Doing Your Own Research

Worksheets

Tracking Your Treatment

View Worksheet
  • 32Share on Facebook
  • 10Share on Twitter
  • 30Share on Pinterest
  • 20Share on Reddit
  • 12Share on LinkedIn
  • 25Share on Email
Category: Resources

Return to The Blog

About The IgAN Team

Previous Post:IgA Nephropathy Foundation Announces Launch of Medical and Scientific Advisory Board
Next Post:Understanding Your Treatment Options
Donate
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Quick Links

  • About Us
  • Financials
  • Patient Resources
  • Research
  • Contact Us
  • Join Our Efforts
  • Privacy Policy

Contact Us

(848) 298-4618

PO Box 1322 Wall, NJ 07719

© 2025 All Rights Reserved.

IgAN Foundation Newsletter

Subscribe to our newsletter below!

First Name
Last Name
Enter your email address

No thanks, I’m not interested!

References

  • Hall, Y.N., Fuentes, E.F., Chertow, G.M. et al. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5, 10 (2004). https://doi.org/10.1186/1471-2369-5-10
  • Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, et al. (2012) Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet 8(6): e1002765. doi:10.1371/journal.pgen.1002765